9th HPAPI: Development and Manufacturing of Highly Potent Active Pharmaceutical Ingredients (APIs)

9th HPAPI Summit Brings Industry Experts Together in Milan to Advance Highly Potent API Development and Manufacturing

The 9th HPAPI: Development and Manufacturing of Highly Potent Active Pharmaceutical Ingredients (APIs) successfully brought together pharmaceutical and biotechnology professionals, CDMOs, technology providers, and industry experts in Milan on September 16–17, 2026, for two days of knowledge exchange, technical discussion, and meaningful networking.

Held at the Ramada Plaza Milano, the 9th HPAPI Summit provided a focused platform for professionals working across the highly potent API lifecycle to discuss the evolving challenges and opportunities shaping HPAPI development, manufacturing, containment, occupational safety, quality, and facility design.

As the HPAPI landscape continues to evolve alongside the growth of oncology pipelines, targeted therapies, antibody-drug conjugates (ADCs), and other highly potent compounds, the summit offered practical insights into how the industry is adapting to increasingly complex development and manufacturing requirements.

Two Days of Expertise, Innovation and Industry Exchange

The program brought together experts from across the pharmaceutical and manufacturing ecosystem to explore key topics including:

• HPAPI process development and manufacturing
• Scale-up and technology transfer
• Occupational toxicology and exposure risk assessment
• Advanced containment and facility design
• Cleaning and decontamination strategies
• GMP and contamination control
• Automation, robotics, and digital manufacturing
• CDMO partnerships and outsourcing strategies
• Emerging technologies supporting safer and more efficient HPAPI operations

Through technical presentations, expert discussions, interactive sessions, and networking opportunities, attendees had the opportunity to exchange practical experiences and discuss solutions to some of the most pressing challenges facing highly potent compound development and manufacturing today.

Connecting Expertise with Real-World Challenges

Beyond the conference sessions, networking remained an important part of the summit experience. Dedicated networking opportunities and the HPAPI business dinner provided participants with an informal setting to continue discussions, exchange perspectives, and build new professional connections.

The combination of technical content and face-to-face interaction created opportunities for professionals from different areas of the industry to connect around shared challenges, emerging technologies, and potential collaborations.

A Special Thank You to Our Speakers

The success of the 9th HPAPI Summit would not have been possible without the contribution of our speakers and industry experts.

We would like to sincerely thank every speaker who shared their knowledge, experience, case studies, and perspectives with the HPAPI community. Your expertise and willingness to engage in open discussion helped make the program practical, relevant, and valuable for all participants.

From development and manufacturing to occupational safety, containment, quality, engineering, and emerging technologies, the breadth of expertise represented at the summit reflected the increasingly multidisciplinary nature of HPAPI operations.

Thank You to Our Sponsors and Partners

We would also like to extend our sincere appreciation to all sponsors, partners, and solution providers who supported the 9th HPAPI Summit.

Your contribution helped create a valuable environment where pharmaceutical and biotechnology professionals could discover new technologies, discuss industry challenges, and connect with companies developing solutions for the highly potent API landscape.

We are grateful for your continued support and for the opportunity to bring innovative technologies and industry expertise together under one roof.

Looking Ahead

The successful 9th edition of the HPAPI Summit highlighted the importance of collaboration, knowledge sharing, and continuous innovation as the industry responds to the growing complexity of highly potent API development and manufacturing.

From advanced containment and occupational safety to automation, digitalization, outsourcing, and facility design, the discussions in Milan demonstrated the wide range of expertise required to safely and efficiently advance HPAPI operations.

We look forward to continuing these conversations and bringing the HPAPI community together for future editions.

For more details on the upcoming editions, please contact Emma at emma@etapahub.com or Irina at irina@etapahub.com. 

Thank you to everyone who joined us in Milan — our speakers, sponsors, partners, and attendees — for making the 9th HPAPI Summit a successful and engaging edition.

Etapa Pharma Team